pyrazines has been researched along with Bunyaviridae Infections in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Li, W; Song, R | 1 |
| Conrad, BL; Furuta, Y; Gowen, BB; Hickerson, BT; Jung, KH; Li, R; Miao, J; Nielson, S; Reynolds, ES; Rigas, JD; Thangamani, S; Van Wettere, AJ; Wang, Z; Westover, JB | 1 |
| Arima, N; Baba, M; Okamoto, M; Saijo, M; Sakakibara, N; Toyama, M | 1 |
| Saijo, M | 1 |
| Conrad, BL; Furuta, Y; Gowen, BB; Hickerson, BT; Jung, KH; Li, R; Miao, J; Nielson, S; Rigas, JD; Van Wettere, AJ; Wang, Z; Westover, JB | 1 |
| Furuta, Y; Gowen, BB; Jung, KH; Morrey, JD; Smee, DF; Wong, MH | 1 |
| Bailey, KW; Furuta, Y; Gowen, BB; Jung, KH; Mendenhall, M; Sanders, AB; Sidwell, RW; Wong, MH | 1 |
1 review(s) available for pyrazines and Bunyaviridae Infections
| Article | Year |
|---|---|
Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy.
Topics: Aged, 80 and over; Amides; Animals; Antiviral Agents; Bunyaviridae Infections; China; Female; Humans; Japan; Male; Mice; Mice, Knockout; Middle Aged; Mortality; Phlebovirus; Pyrazines; Republic of Korea; Syndrome; Thrombocytopenia | 2018 |
6 other study(ies) available for pyrazines and Bunyaviridae Infections
| Article | Year |
|---|---|
Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705).
Topics: Adult; Amides; Antiviral Agents; Bunyaviridae Infections; Humans; Male; Middle Aged; Phlebovirus; Pyrazines; Treatment Outcome | 2020 |
Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir.
Topics: Amides; Animal Structures; Animals; Antiviral Agents; Bunyaviridae Infections; Chemoprevention; Cricetinae; Disease Models, Animal; Inflammation; Interferon Type I; Pyrazines; STAT2 Transcription Factor; Treatment Outcome | 2017 |
Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors.
Topics: Amides; Amodiaquine; Animals; Antiviral Agents; Bunyaviridae; Bunyaviridae Infections; Cell Line; Chlorocebus aethiops; Fever; Humans; Microbial Sensitivity Tests; Pyrazines; Ribavirin; Thrombocytopenia; Virus Replication | 2017 |
Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with Favipiravir.
Topics: Amides; Animals; Animals, Genetically Modified; Antiviral Agents; Bunyaviridae Infections; Cricetinae; Disease Models, Animal; Disease Susceptibility; Genotype; Humans; Models, Biological; Phenotype; Phlebovirus; Pyrazines; STAT2 Transcription Factor | 2017 |
Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models.
Topics: Amides; Animals; Antiviral Agents; Bunyaviridae Infections; Chlorocebus aethiops; Cricetinae; Disease Models, Animal; Female; Liver; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Nucleosides; Pyrazines; Serum; Survival Analysis; Treatment Outcome; Vero Cells; Viral Load | 2010 |
In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections.
Topics: Amides; Animals; Antiviral Agents; Arenaviridae Infections; Bunyaviridae Infections; Cell Line; Cricetinae; Haplorhini; Liver; Mice; Pyrazines; Ribavirin; Viral Load | 2007 |